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Abstract
Background: The production of reactive oxygen species (ROS) during pneumococcal meningitis (PM) leads to severe
DNA damage in the neurons and is the major cause of cell death during infection. Hence, the use of antioxidants as
adjuvant therapy has been investigated. Previous studies have demonstrated the possible participation of apurinic/
apyrimidinic endonuclease (APE1) during PM. The aims of this study were to investigate the APE1 expression in the
cortical and hippocampal tissues of infant Wistar rats infected with Streptococcus pneumoniae and its association with
cell death and understand the role of vitamin B6 (vitB6) as a protective factor against cell death.
Methods: APE1 expression and oxidative stress markers were analyzed at two-time points, 20 and 24 h post infection
(p.i.), in the cortex (CX) and hippocampus (HC) of rats supplemented with vitB6. Statistical analyses were performed by
the nonparametric Kruskal–Wallis test using Dunn’s post test.
Results: Our results showed high protein levels of APE1 in CX and HC of infected rats. In the CX, at 20 h p.i., vitB6
supplementation led to the reduction of expression of APE1 and apoptosis-inducing factor, while no significant changes
in the transcript levels of caspase-3 were observed. Furthermore, levels of carbonyl content and glutamate in the CX were
reduced by vitB6 supplementation at the same time point of 20 h p.i.. Since our data showed a significant effect of vitB6
on the CX at 20 h p.i. rather than that at 24 h p.i., we evaluated the effect of administering a second dose of vitB6 at 18 h
p.i. and sacrifice at 24 h p.i.. Reduction in the oxidative stress and APE1 levels were observed, although the latter was not
significant. Although the levels of APE1 was not significantly changed in the HC with vitB6 adjuvant therapy, vitB6
supplementation prevented the formation of the truncated form of APE1 (34 kDa) that is associated with apoptosis.
Conclusions: Our data suggest that PM affects APE1 expression, which can be modulated by vitB6. Additionally, vitB6
contributes to the reduction of glutamate and ROS levels. Besides the potential to reduce cell death and oxidative
stress during neuroinflammation, vitB6 showed enhanced effect on the CX than on the HC during PM.
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Background
Pneumococcal meningitis (PM) is one of the most
common and serious infections of the central nervous
system (CNS). Despite the efficacy of antibiotic therapy,
cellular injuries and neurological sequelae are still
common. Cortical necrosis and hippocampal apoptosis
are associated to PM in human and animal models. Over
the last decades, studies have shown that reactive oxygen
species (ROS) play a central role in brain damage during
bacterial meningitis and treatment with various radical
scavengers/antioxidants inhibited neuronal loss [1–3].
Oxidative stress is one of the main causes of DNA dam-
age resulting in base modifications and single- and
double-strand breaks. The base excision repair (BER)
pathway is involved in the repair of oxidized DNA
lesions in neurons and has been associated with several
neurodegenerative diseases [4, 5]. The apurinic/apyrimi-
dinic endonuclease 1 (APE1) acts in the BER pathway
upon removal of damaged bases by glycosylases [6, 7]. In
addition, APE1 is a multifunctional protein related to
DNA repair and regulation of gene expression and
therefore has emerged as an important factor in immune
and inflammatory responses [8].
APE1 is highly expressed in some regions of the
central nervous system and promotes survival of neu-
rons after oxidative stress [4, 5]. Cerebral ischemia and
reperfusion induce accumulation of oxidative DNA
lesions in the brain, which, if not promptly repaired,
may trigger cell death. Conversely, reduction in APE1
expression was observed in the hippocampus following
hypoxic–ischemic injury [9], in the cortex after com-
pression injury [10] and in the spinal cord after ischemia
[11]. The decrease in APE/Ref-1 expression was also
associated with cortical infarction after photothrombotic
cerebral ischemia [12]. In the caudal region of the spinal
cord, a strong correlation between DNA damage and the
increase in APE1 mRNA levels was observed after trau-
matic spinal cord injury [13]. However, APE1 expression
in brain tissues has been poorly studied during infec-
tious disease, although some data have shown associ-
ation of APE1 polymorphism with the occurrence of
bacterial meningitis [14, 15].
Previously, in vivo experiments showed that supple-
mentation of vitamin B6 (vitB6) during experimental
PM improved the cell survival by reducing hippocampal
apoptosis through maintenance of cellular energy stores
[16]. VitB6 is a hydro-soluble molecule naturally found
in several foods and available as a dietary supplement. It
is estimated that it performs around 4% of catalytic
activity in the human system as a coenzyme mostly in-
volved in the protein synthesis. Additionally, vitB6 con-
tributes to a wide range of functions in human
metabolic processes of carbohydrates and lipids and
plays an important role in the cognitive development by
biosynthesis of neurotransmitters [17]. Epidemiological
studies indicate that vitB6 has beneficial effects on
human health by protecting against several pathologies
such as cancer, diabetes, cardiovascular disease, and
neurological disorders [18]. The vitamin deficiency is
associated with immune system impairments such as
reduction in the numbers and functions of immuno-
logical cells [19], and intake of vitB6 is linked to the
protection against inflammation [20].
Overall, since multiple literature evidences show APE1
as an important enzyme during oxidative stress condi-
tions in the brain, we focused on investigating its expres-
sion in the cortex (CX) and hippocampus (HC) during
experimental PM after vitB6 treatment which may
contribute to the understanding of the role for this
vitamin as an adjuvant therapy to reduce oxidative stress
during neuroinflammatory diseases.
Methods
Infant rat model of pneumococcal meningitis
Animal studies were approved by the Animal Care and Ex-
perimentation Committee of Canton of Bern, Switzerland,
and followed the guidelines of the National Institutes of
Health for performing animal experiments. Wistar rats
were infected intracisternally on postnatal day 11 with
10 μL of saline containing S. pneumoniae (7 × 105 cfu/mL),
with a 32-gauge needle. Infected animals were randomly
divided in two groups: the first group received the treat-
ment with vitB6 subcutaneously (s.c.; 600 mg/kg, 0 h post
infection (p.i.)), while the second group received an equal
volume (360 μL) of saline. Uninfected control animals were
injected with 10 μL of sterile saline solution in the cisterna
magna. Cerebrospinal fluid (CSF) was obtained by puncture
of the cisterna magna at 18 h p.i., and 5 μL was cultured
qualitatively to document meningitis. Infected animals were
confirmed by positive bacterial titers in the CSF (log10 6.4–
log10 6.8 cfu/mL) and clinical signs according to the
following score system: 1 for comatose animals; 2 for rats
that do not turn upright after positioning on the back; 3 for
animals that turn within 30 s; 4 for animals that turn up-
right less than 5 s; and 5 for rats with normal activity [2].
Despite the vitB6 treatment, the infected animals did not
show a significant difference about CSF bacterial titers,
weight, and clinical course of meningitis. All animals
received antibiotic therapy at 18 h p.i. (ceftriaxone, 100 mg/
kg subcutaneous injection; Roche Pharma, Reinach,
Switzerland). Animals were sacrificed at predetermined
time points, 20 h (in total n = 19) and 24 h (in total n = 20)
p.i. by an overdose of intraperitoneally administered pento-
barbital (100 mg/kg). These chosen time points have been
associated with high score of apoptosis during PM.
Another group of infected rats (n = 12) was subjected to
similar treatment as previously described; however, six
animals received an extra dose of vitB6 supplementation
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at the same time point as antibiotic therapy, while the
others (n = 6) received the same volume of saline, and
were sacrificed at 24 h p.i.. The animals that received vitB6
at the time of infection were named “PM/pre sup vitB6,”
while the animals supplemented with the second dose of
vitB6 were named “PM/pre pos sup vitB6” and its
control PM2. Since no statistical differences between
PM and PM2 were observed, these animals were only
named as PM.
In resume, the animals evaluated in this work were
distributed into the following groups: uninfected control
animals (CTRL) 20 h (n = 5), uninfected control animals
(CTRL) 24 h (n = 5), infected animals (PM) without
vitB6 treatment 20 h p.i. (n = 5), infected animals (PM)
without vitB6 treatment 24 h p.i. (n = 5), infected
animals plus vitB6 treatment (PM/pre sup vitB6) 20 h
p.i. (n = 9), infected animals plus vitB6 treatment (PM/
pre sup vitB6) 24 h p.i (n = 10), infected animals without
the second dose of vitB6 (PM) 24 h (n = 6), and infected
animals plus the second dose of vitB6 treatment (PM/
pre pos sup vitB6) 24 h p.i. (n = 6). These animals were
used in all assays described below.
After perfusion with ice-cold phosphate buffer saline
(PBS), the brains were dissected, rolled on a filter paper
to remove the meninges, and cut into two hemispheres,
and the CX and HC were isolated in ice cold PBS from
both hemispheres. The right half of the brains were
frozen on dry ice and stored at − 80 °C for protein ex-
traction and western blot, carbonyl content, and glutam-
ate level assays, while the left half was kept in RNAlater
(Ambion Europe Ltd., Huntingdon, Cambridgeshire,
UK) in PBS (v/v 1:2) at 4 °C for RNA extraction.
RNA isolation and RT-qPCR
Total RNA was extracted from the tissue samples of CX
and HC from animals using RNeasy® Lipid Tissue kit
(QIAGEN, Basel, Switzerland) and purified with RNeasy
columns (QIAGEN, Basel, Switzerland). The quantifica-
tion and assessment of RNA integrity were performed
on the Agilent 2100 bioanalyzer platform (RNA 6000 Nano,
Agilent technologies, Waldbronn, Germany) and validated
on the NanoDrop® (NanoDrop, Wilmington, USA) quantifi-
cation device. The OmniScript First Strand cDNA Synthesis
System (Qiagen) was used with 2 μg total RNA and oligo-dT
primers (Promega, Madison, WI, USA), following the manu-
facturer’s protocol. To minimize the methodological effects
interfering with cDNA quantification, all total RNA samples
were processed simultaneously. Template cDNA was ampli-
fied using the Step One Detection system (Applied
Biosystems, Foster, CA, USA). SYBR-green PCR Master Mix
(Qiagen, Basel, Switzerland) was used for the amplification
and detection of APE1, apoptosis-inducing factor (AIF),
caspase-3 (Casp-3), and glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) transcripts. The specificity of the
SYBER-green signal was validated by the presence of single
and sharp melting peak for every PCR run. The amount of
template used for the PCR reaction was normalized to the
commonly used housekeeper gene GAPDH. APE1 oligo-
nucleotide primers used in this study were designed with
Primer 3 with the following sequences: forward 5′ TGCTC
CAGACGCCTAAGGGCTTT 3′ and reverse 5′ TCTGGCT
CGGACTTGGGTTCTTCC 3′, while the primers for AIF
(RTPrimerDB ID: 3945), Casp-3 (RTPrimerDB ID: 1207),
and GAPDH (RTPrimerDB ID: 192) were obtained from the
public database RTprimerDB.
Protein extraction and western blot
The frozen HC and CX samples were homogenized in
1:3 (w/v) and 1:5 (w/v) ratios, respectively, in ice-cold
homogenization buffer (50 mM Tris, 2 mM MgCl2 at
pH 8.0, 0.4 mM PMSF, 0.4 mM NaCl, 1% NP-40) with
TissueRuptor, a rotor-stator homogenizer (Qiagen, Basel,
CH). The homogenates were centrifuged (10,000×g,
15 min, 4 °C), supernatant transferred, aliquoted, and
frozen on dry ice. The protein concentration in the
supernatant was measured using Bradford assay. For
assessing APE1 levels, 10 μg of total protein of
hippocampal or cortical protein extracts was separated
on 12% SDS-PAGE and transferred onto a PVDF
membrane. The membrane was blocked for 1 h in PBS
containing 5% milk and 0.01% Tween 20 and incubated
overnight with monoclonal mouse anti-APE1 (1:1000;
Santa Cruz Biotechnology, Santa Cruz, CA, USA) and
anti-β actin (1:1000; Santa Cruz Biotechnology, Santa
Cruz, CA, USA) antibodies. The blots were washed with
PBST and incubated with the secondary antibody HRP
conjugate (1:1000; Santa Cruz Biotechnology, Santa
Cruz, CA, USA) for 1 h, exposed to ECL Prime western
blotting detection reagent (Amersham), and analyzed by
Chemidoc (Biorad).
Glutamate determination
Glutamate levels were determined using the glutamate
assay kit (BioVision, CA, USA). Briefly, total protein
extract from both tissues was homogenized with the
provided assay buffer and mixed with the glutamate
developer and enzyme mix. Next, the total reaction was
incubated for 30 min at 37 °C in dark, followed by meas-
urement of samples at 450 nm in a microplate reader
(MicroQuant, Biotek).
Carbonyl content
The carbonyl content was determined spectrophotomet-
rically using the 2,4-dinitrophenylhydrazine (DNPH)-la-
beling. Briefly, a set of protein samples from animals,
with a final volume of 200 μL (1 mg/mL), was incubated
for 1 h with 200 μL DNPH in the dark, while another
set of the same samples was incubated with 200 μL of
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HCl for 1 h. All samples were sequentially extracted with
50% (w/v) trichloroacetic acid at − 20 °C for 1 h and
washed three times with ethanol/ethyl acetate 1:1 (v/v).
The resulting precipitate was dissolved in 500 μL of 6 M
guanidine hydrochloride, and the samples were mea-
sured at 370 nm in a microplate reader (MicroQuant,
Biotek). Difference spectrum of the samples treated with
DNPH versus similar samples treated with HCl was used
as the corrected absorbance (CA). Final results were
obtained from the following calculation: protein car-
bonyl (nmol/mL) = [(CA)/0.011 μM−1] (500 μL/200 μL).
Statistical analysis
Samples were tested for normal distribution using
D’Agostino & Pearson omnibus normality test (Graph-
Pad Prism, version 4.0, GraphPad Software Inc., San
Diego, CA, USA). The comparisons among three or
more unmatched groups were performed by the non-
parametric Kruskal–Wallis test while differences
between two groups were tested using Dunn’s post test
(GraphPad Prism, version 4.0, GraphPad Software Inc.,
San Diego, CA, USA). A value of p < 0.05 was considered
statistically significant.
Results
Establishing experimental pneumococcal meningitis
All infected animals developed meningitis as evidenced
by the positive bacterial CSF titers at 18 h p.i.. Within
this time period, clinical signs of meningitis were docu-
mented in all the infected animals, but not in control
animals (data not shown).
Analysis of transcript expression in cortex and
hippocampus during pneumococcal meningitis
The mRNA levels of APE1, AIF, and Casp-3 in the CX
and HC at 20 and 24 h during PM and PM/pre sup
vitB6 were determined. APE1 levels in CX/20 h did not
show a significant difference among the various groups
while CX/24 h showed lower levels of APE1 in the
animals with PM compared to CTRL (Fig. 1a). AIF
mRNA levels in the CX/20 h were significantly de-
creased in the PM/vitB6 group compared to those in the
PM, while in the CX/24 h, a significant reduction in the
AIF expression in the groups PM/vitB6 and PM was
observed (Fig. 1b). Casp-3 did not show significant alter-
ations in the CX/20 h, but was significantly higher com-
pared to CTRL in the CX/24 h of PM/vitB6 group
(Fig. 1c). Despite the vitB6 supplementation, infection in
the animals resulted in significant reduction of APE1
and Casp-3 mRNA levels compared to CTRL animals in
the HC/20 h tissue (Fig. 1d, f ). All three studied genes
were significantly reduced in the HC/24 h of PM/vitB6
animals compared to the CTRL group (Fig. 1d–f ). Con-
comitantly, in the HC/24 h, lower AIF mRNA levels
were noted in the animals from PM/vitB6 group
compared to PM (Fig. 1e).
Assessment of protein levels of APE1
Cortical APE1 expression showed higher levels during
PM infection at both time points compared to CTRL
animals (Fig. 2a). Comparing animals that received prior
vitB6 supplementation and those without vitB6, APE1
protein showed lower levels in the CX/20 h, but an in-
crease in APE1 (37 kDa) was observed in CX/24 h
(Fig. 2a) in animals treated with vitB6. Surprisingly, a
slower migrating form of APE1 was observed in the CX/
24 h from animals with PM and PM/pre-sup vitb6; how-
ever, the same event was not observed in the CX/20 h.
Consequently, these groups showed higher levels of total
APE1 protein compared to CTRL animals (Fig. 2a, b). In
the hippocampus tissue, PM infection caused a signifi-
cant increase of APE1 protein at 20 h p.i. compared to
CTRL animals (Fig. 2c). Although APE1 reduction has
been noted in HC/20 h after vitB6 administration, it was
not sufficient to promote significant changes in the
DNA repair enzyme expression levels (Fig. 2c). Notably,
complete cleavage of APE1 protein resulting in a smaller
protein around 33–34 kDa was observed in the HC of
some infected animals without vitB6 supplementation.
However, this cleaved protein was not detected in the
HC from animals supplemented with vitB6 or from the
CTRL group (Fig. 2d).
Vitamin B6 promotes lower glutamate levels and
carbonyl content in the CX during PM
Glutamate, a major excitatory amino acid neurotrans-
mitter, causes apoptotic neuronal cell death at high
concentrations via increased oxidative stress and is a
substrate of several vitB6-dependent enzymes. Analysis
performed in the CX/20 h showed accumulation of
glutamate levels during infection and its marginal but
non-significant reduction after vitB6 supplementation.
Nonetheless, the CX/24 h of infected animals supple-
mented with vitB6 showed significantly higher glutamate
levels compared to the other groups (Fig. 3a). Glutamate
levels were significantly reduced in the HC/20 h after
vitB6 supplementation while no significant change was
observed among groups in the HC/24 h (Fig. 3b). Cor-
roborating the glutamate data, animals supplemented
with vitB6 had lower concentrations of carbonylated
proteins in the CX/20 h compared to animals without
treatment, while no significant difference in the carbonyl
content was noted in the CX/24 h among the various
groups (Fig. 3c). Contrary to prior observations in the
glutamate levels, the carbonyl content in HC/20 h and
HC/24 h was significantly increased in the animals after
vitB6 administration (Fig. 3d).
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Effect of an additional dose of vitB6 supplementation on
APE1 expression levels in the PM cortex
Since vitB6 had an enhanced effect in the cortex at 20 h
p.i. compared to 24 h p.i. (Figs. 2a and 3a), the effect of an
additional dose of vitB6 on the APE1 expression in the
cortex was studied. Since vitB6 supplementation did not
significantly influence the expression levels in the hippo-
campal tissue, it was not chosen for this study. A qualita-
tive but statistically non-significant decrease in the total
amount of APE1 protein was noted in the vitB6 group.
The 70 kDa band of APE1 protein remained even after an
extra dose of vitB6 (Fig. 4a). Additionally, carbonylated
content was significantly reduced in the CX 24 h p.i. from
animals pre pos supplemented with vitB6 (Fig. 4b).
Discussion
The role of APE1 during oxidative stress response in the
brain has been previously described [4, 5]. Over the last
Fig. 1 Effects of pre supplementation of vitamin B6 on APE1, AIF, and Casp-3 mRNA expression levels. Gene expression was determined in the CX (a, b, c)
and HC (d, e, f) by real-time PCR and the fold change was calculated using the ΔCq method. Values were transformed to percentage using the control
group at 20 h post infection as 100%. Each column data expresses the mean percentage (± SEM) relative to control 20 h. Comparisons between columns
which show p< 0.05 were significant in Dunn’s post test. Groups: uninfected control animals (CTRL) 20 h (n= 5), uninfected control animals (CTRL) 24 h (n
= 5), infected animals (PM) without vitB6 treatment 20 h p.i. (n= 5), infected animals (PM) without vitB6 treatment 24 h p.i. (n= 5), infected animals plus
vitB6 treatment (PM/pre sup vitB6) 20 h p.i. (n= 8), infected animals plus vitB6 treatment (PM/pre sup vitB6) 24 h p.i. (n= 10)
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decade, APE1 has been associated with inflammation
apart from its apurinic/apirimidinic endonuclease
function [8]. In this work, our study demonstrated that
APE1 expression can be modulated during PM accord-
ing to the brain tissue, time of infection, and vitB6
supplementation.
Neuronal death in the CX during PM has been pre-
dominantly associated with necrosis [21]. However, our
data suggest significant increase in AIF levels in the CX/
20 h. In the previous studies using similar experimental
model of PM, presence of AIF had been reported in the
dentate gyrus of HC, where apoptosis is the predomin-
ant type of death [22, 23]. Nevertheless, a body of
evidences has revealed an AIF-mediated programmed
necrosis, which is initiated by the sequential activation
of well-known proteins including PARP-1, calpain, and
Bax [24, 25]. AIF translocation from the mitochondria to
cytosol and nuclei has also been noted in primary
cortical cells after glutamate induction [26]. Our data
also showed significantly higher glutamate levels in the
CX/20 h p.i. during PM compared to CTRL, which
corroborate the AIF data. Since glutamate is known to
activate N-methyl-D-aspartate (NMDA) receptor leading
to influx of Ca2+, the excessive amount of ions in the cell
promotes activation of calpain I and neuronal nitric
oxide synthase (nNOS), thereby increasing the RNS/
ROS levels.
DNA damage due to free radicals promotes PARP-1
overactivation and results in the energy depletion
followed by AIF-mediated necrosis [24]. Interestingly,
the amount of APE1 transcripts showed similar expres-
sion pattern compared to the two important proteins
related to cell death, AIF, and Casp-3. Although, our
data showed reduced levels of Casp-3 mRNA after PM,
activity of this cysteine protease has been demonstrated
mainly in the HC from PM animals [27]. Western blot
analyses for the Casp-3 precursor protein (32 kDa)
showed decreased immunoreactivity in the course of the
disease, while an increase in the 17-kDa cleaved form of
active Casp-3 was observed [27]. However, two micro-
array studies using similar experimental model of PM
did not show significant upregulation of Casp-3 [16, 23],
which can be the result of factors such as energy
depletion [28] and nitrative/oxidative stress [29, 30]. In
fact, neurons are susceptible to both energy depletion
and oxidative stress. Therefore, the notable presence of
APE1, AIF, and Casp-3 in the HC and CX may suggest
an important tissue-dependent coordination among
them during neuronal stress and may reinforce the idea
of important mechanisms of cell death in the HC in
Fig. 2 Western blotting (WB) analysis of the cortex (a, b) and hippocampus (c, d) tissues from Winstar rats infected with PM under vitB6 pre-supplementation
treatment: a Significant reduction in the expression of APE1 is observed in the CX/20 h in the PM/pre sup vitB6 animals compared to the PM animals; b In the
CX/24 h, WB from infected animals showed different sizes of APE1 (37 and 70 kDa) which resulted in a higher expression as compared to the control group as
observed in a; c In HC/20 h, a significant increase in APE1 protein level was observed in the PM animals compared to the CTRL groups; dWB from the HC
showed a cleaved form of APE1 in some infected animals which was not detected in the lysates from animals which received vitB6. β-actin was measured as
the loading control and was used for data normalization. Data are reported as the mean percentage relative to control of each time point ± SEM. Groups for
the CX: uninfected control animals (CTRL) 20 h (n= 5), uninfected control animals (CTRL) 24 h (n=3), infected animals (PM) without vitB6 treatment 20 h p.i. (n
=5), infected animals (PM) without vitB6 treatment 24 h p.i. (n= 3), infected animals plus vitB6 treatment (PM/pre sup vitB6) 20 h p.i. (n=9), and infected
animals plus vitB6 treatment (PM/pre sup vitB6) 24 h p.i. (n= 3). Groups for the HC: uninfected control animals (CTRL) 20 h (n=3), uninfected control animals
(CTRL) 24 h (n=3), infected animals (PM) without vitB6 treatment 20 h p.i. (n= 5), infected animals (PM) without vitB6 treatment 24 h p.i. (n=3), infected
animals plus vitB6 treatment (PM/pre sup vitB6) 20 h p.i. (n= 4), and infected animals plus vitB6 treatment (PM/pre sup vitB6) 24 h p.i. (n=3)
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addition to Casp-3-mediated mechanism. Collectively,
we propose that AIF may play a more important role in
the neuronal death compared to Casp-3.
Additionally, this work also showed elevated levels of
APE1 protein during PM compared to CTRL and an
intriguing post-translational modification (PTM) in the
CX/24 h p.i., wherein a slower migrating form of APE1
(70 kDa) was observed in the infected animals with and
without vitB6. Although the identity of this band has not
been determined, we suggest a possible mechanism to
address APE1 degradation since both mRNA and pro-
tein (37 kDa) levels of APE1 are lower in CX/24 h from
PM animals. The protein ubiquitin E3 ligase MDM2,
involved in the ubiquitination of p53 and responsible for
its degradation, was previously demonstrated to interact
directly with APE1 and promotes its ubiquitination,
although the precise function of APE1 ubiquitination is
not clear as yet [31]. In our work, elevated levels of
APE1 and a truncated form of APE1 protein (34 kDa)
was observed in the animals that did not receive vitB6
treatment. Conversely, vitB6 showed a protective effect
in the hippocampus of the animals preventing the cleav-
age of APE1. The truncated form of APE1 is associated
with apoptosis [32–34]. It has been demonstrated in
human promyelocytic leukemia HL-60 cells that this
truncated form of APE1 was involved in the apoptosis
and DNA fragmentation, and its activation was mediated
by Casp-3 [35]. Interestingly, apoptosis is the major type
of cell death in the hippocampus during PM and is pre-
dominantly mediated via Casp-3 [27]. This observation
suggests the possible connection between Casp-3 and
APE1 during apoptotic cell death in the HC during PM.
The effect of vitB6 supplementation on the CX was
mainly at the time point 20 h p.i.. The animals showed
reduced levels of AIF, APE1, glutamate, and protein
carbonyl at this time point. VitB6 is known to increase
gamma-aminobutyric acid (GABA) levels, a major
neurotransmitter acting in the inhibition of neurons,
and may protect hippocampal CA1 pyramidal cells from
ischemic damage [36]. Additionally, glutamate is an
Fig. 3 Levels of glutamate (a, b) and carbonyl content (c, d) in the CX and HC tissue from animals with PM after vitB6 supplementation.
Glutamate level is significant increased during infection in both tissues and vitB6 has an effective influence up to 20 h p.i.. Reduction of carbonyl
content were significant only in the CX/20 h in PM/pre sup vitB6. In contrast, in the HC, the vitB6 is associated to the highest level of carbonyls.
Values were transformed to percentage using the control group at 20 h post infection as 100%. Each column data expresses the mean
percentage (± SEM) relative to control 20 h from at least three or more animals. Comparison between columns which show p < 0.05 were
significant in Dunn’s post test. Groups for the CX: uninfected control animals (CTRL) 20 h (n = 3), uninfected control animals (CTRL) 24 h
(n = 5), infected animals (PM) without vitB6 treatment 20 h p.i. (n = 5), infected animals (PM) without vitB6 treatment 24 h p.i. (n = 5),
infected animals plus vitB6 treatment (PM/pre sup vitB6) 20 h p.i. (n = 9), and infected animals plus vitB6 treatment (PM/pre sup vitB6)
24 h p.i. (n = 9). Groups for the HC: uninfected control animals (CTRL) 20 h (n = 3), uninfected control animals (CTRL) 24 h (n = 3), infected
animals (PM) without vitB6 treatment 20 h p.i. (n = 3), infected animals (PM) without vitB6 treatment 24 h p.i. (n = 3), infected animals
plus vitB6 treatment (PM/pre sup vitB6) 20 h p.i. (n = 9), and infected animals plus vitB6 treatment (PM/pre sup vitB6) 24 h p.i. (n = 4)
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important precursor of GABA and glutamate decarb-
oxylase (GAD) is the main enzyme specialized to
synthesize GABA, which uses vitB6 as the cofactor [37].
Therefore, our data suggests a possible increase in the
GAD activity and GABA concentrations although not
experimentally validated. Consistent with this hypoth-
esis, our study showed that animals treated with vitB6
had reduced levels of glutamate in both tissues at 20 h
p.i., while the carbonyl content was reduced mainly in
the CX at the same time point. Further, the chosen time
points suggested a limited efficacy of this vitamin that
was noted after the administration of an additional dose
of vitB6. Animals that received two doses of vitB6
showed decreased APE1 protein expression and carbonyl
content compared to those that received a single dose.
Although reduced levels of hippocampal apoptosis have
been reported in the prior study with additional
supplementation of vitB6 at the same time point [16], it
would be interesting to study the kinetics of vitB6
concentration to better understand the effects of vitB6
supplementation.
APE1 emerges as an intriguing candidate involved in
the intricate network of cell death proteins once it
responds directly to oxidative stress mediated by vitB6.
Briefly, during PM, higher levels of glutamate induces
activation of NMDA receptors promoting ROS produc-
tion leading to DNA damage and, consequently, the re-
quirement of DNA repair enzymes in the CX and cleavage
of this protein in the HC. Changes in the permeability of
the mitochondrial membrane promote the release of AIF
and trigger apoptosis. Conversely, vitB6 supplementation
reduces glutamate concentrations via GABA formation
that block NMDA receptors and the following steps in the
pathway. Hence, vitB6 promotes reduction of glutamate
and oxidative damage and lowers the APE1 levels. Consid-
ering the interval of 18 to 24 h as the cell death hallmark
during PM, we conclude that the maximum effect of vitB6
occurs at the beginning of the acute phase in CX.
Fig. 4 Effect of an additional dose of vitB6 on APE1 protein expression (a) and carbonyl content (b) in the CX/24 h. Western blot images reveal a
reduction in the expression of different APE1 forms after vitB6 pre/post supplementation as indicated in the graph (a). Carbonyl content was
significantly reduced after an extra dose of vitB6 (b). Each column from carbonyl data expresses the mean percentage (± SEM) relative to control
CX/20 h (showed in Fig. 3c). Comparison between columns which show p < 0.05 were significant in Dunn’s post test. Groups: uninfected control
animals (CTRL) (n = 3), infected animals (PM) without vitB6 treatment (n = 6), infected animals plus vitB6 treatment (PM/pre sup vitB6) (n = 9), and
infected animals plus second dose of vitB6 treatment (PM/pre pos sup vitB6) (n = 5)
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Conclusions
VitB6 pre-supplementation has a transient effect on the
APE1 expression in the brain during PM. Therefore,
reduced glutamate and carbonyl levels suggest that
APE1 might be responding to ROS levels rather than to
vitB6 itself although the precise mechanism remains to
be uncovered. Consistent with this work, APE1 is emer-
ging as a protein involved in the physiology of PM,
which leaves some questions unanswered: Can the trun-
cated APE1 form found in HC contribute to neuron
death in the HC? Why does APE1 expression differ in
the CX and HC? Besides the DNA repair activity, this
protein is known to perform a variety of functions,
which can be further exploited during PM. Altogether,
vitB6 supplementation seems to show a possible benefi-
cial effect majorly on the APE1 levels during PM which
may be expanded to analyze other potential targets.
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